APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cobalamin API

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Cobalamin API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

23 December 2025193 pages

Choose your research edition.

Industry ResearchCobalamin API Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Cobalamin API Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Cobalamin API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cobalamin API Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Cobalamin API Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Cobalamin API market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Cobalamin API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Cobalamin API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cobalamin API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Cobalamin API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Cobalamin API include Teva (Actavis), Novartis, Merck, Mylan, Pfizer, Huaxin Pharmaceutical, Sanofi-Aventis, RLG Group and Luitpold Pharmaceuticals (Daiichi Sankyo), among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Cobalamin API market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Cobalamin API and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Cobalamin API sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Cobalamin API market size, projected growth trends, production technologies, key applications, and end-use industries.

Cobalamin API Segment by Company

Teva (Actavis)

Novartis

Merck

Mylan

Pfizer

Huaxin Pharmaceutical

Sanofi-Aventis

RLG Group

Luitpold Pharmaceuticals (Daiichi Sankyo)

Jamieson

Endo International

CCEPCD

Bayer HealthCare

ANGELINI

Cobalamin API Segment by Type

Purity≥99%

Purity<99%

Cobalamin API Segment by Application

Cobalamin Injection

Cobalamin Spray

Oral Cobalamin

Cobalamin API Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cobalamin API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cobalamin API and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cobalamin API.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Cobalamin API market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Cobalamin API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Cobalamin API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Cobalamin API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Cobalamin API Industry Trends Table 2. Cobalamin API Industry Drivers Table 3. Cobalamin API Industry Opportunities and Challenges Table 4. Cobalamin API Industry Restraints Table 5. Global Cobalamin API Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Cobalamin API Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Cobalamin API Sales by Manufacturers (t) & (2021-2026) Table 8. Global Cobalamin API Sales Market Share by Manufacturers Table 9. Global Cobalamin API Average Sales Price (USD/kg) of Manufacturers (2021-2026) Table 10. Global Cobalamin API Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Cobalamin API Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Cobalamin API Manufacturers, Product Type & Application Table 13. Global Cobalamin API Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Cobalamin API by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Purity≥99% Table 17. Major Manufacturers of Purity<99% Table 18. Global Cobalamin API Sales by Type 2021 VS 2025 VS 2032 (t) Table 19. Global Cobalamin API Sales by Type (2021-2026) & (t) Table 20. Global Cobalamin API Sales by Type (2027-2032) & (t) Table 21. Global Cobalamin API Sales Market Share by Type (2021-2026) Table 22. Global Cobalamin API Sales Market Share by Type (2027-2032) Table 23. Global Cobalamin API Revenue by Type 2021 VS 2025 VS 2032 (t) Table 24. Global Cobalamin API Revenue by Type (2021-2026) & (t) Table 25. Global Cobalamin API Revenue by Type (2027-2032) & (t) Table 26. Global Cobalamin API Revenue Market Share by Type (2021-2026) Table 27. Global Cobalamin API Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Cobalamin Injection Table 29. Major Manufacturers of Cobalamin Spray Table 30. Major Manufacturers of Oral Cobalamin Table 31. Global Cobalamin API Sales by Application 2021 VS 2025 VS 2032 (t) Table 32. Global Cobalamin API Sales by Application (2021-2026) & (t) Table 33. Global Cobalamin API Sales by Application (2027-2032) & (t) Table 34. Global Cobalamin API Sales Market Share by Application (2021-2026) Table 35. Global Cobalamin API Sales Market Share by Application (2027-2032) Table 36. Global Cobalamin API Revenue by Application 2021 VS 2025 VS 2032 (t) Table 37. Global Cobalamin API Revenue by Application (2021-2026) & (t) Table 38. Global Cobalamin API Revenue by Application (2027-2032) & (t) Table 39. Global Cobalamin API Revenue Market Share by Application (2021-2026) Table 40. Global Cobalamin API Revenue Market Share by Application (2027-2032) Table 41. Global Cobalamin API Sales by Region: 2021 VS 2025 VS 2032 (t) Table 42. Global Cobalamin API Sales by Region (2021-2026) & (t) Table 43. Global Cobalamin API Sales Market Share by Region (2021-2026) Table 44. Global Cobalamin API Sales Forecasted by Region (2027-2032) & (t) Table 45. Global Cobalamin API Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Cobalamin API Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (t) Table 47. North America Cobalamin API Sales by Country (2021-2026) & (t) Table 48. North America Cobalamin API Sales by Country (2027-2032) & (t) Table 49. Europe Cobalamin API Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (t) Table 50. Europe Cobalamin API Sales by Country (2021-2026) & (t) Table 51. Europe Cobalamin API Sales by Country (2027-2032) & (t) Table 52. Asia Pacific Cobalamin API Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (t) Table 53. Asia Pacific Cobalamin API Sales by Country (2021-2026) & (t) Table 54. Asia Pacific Cobalamin API Sales by Country (2027-2032) & (t) Table 55. South America, Middle East and Africa Cobalamin API Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (t) Table 56. South America, Middle East and Africa Cobalamin API Sales by Country (2021-2026) & (t) Table 57. South America, Middle East and Africa Cobalamin API Sales by Country (2027-2032) & (t) Table 58. Global Cobalamin API Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Cobalamin API Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Cobalamin API Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Cobalamin API Revenue Market Share by Region (2021-2026) Table 62. Global Cobalamin API Revenue Market Share by Region (2027-2032) Table 63. Teva (Actavis) Company Information Table 64. Teva (Actavis) Business Overview Table 65. Teva (Actavis) Cobalamin API Sales (t), Price (USD/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Teva (Actavis) Cobalamin API Product Portfolio Table 67. Teva (Actavis) Recent Development Table 68. Novartis Company Information Table 69. Novartis Business Overview Table 70. Novartis Cobalamin API Sales (t), Price (USD/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Novartis Cobalamin API Product Portfolio Table 72. Novartis Recent Development Table 73. Merck Company Information Table 74. Merck Business Overview Table 75. Merck Cobalamin API Sales (t), Price (USD/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Merck Cobalamin API Product Portfolio Table 77. Merck Recent Development Table 78. Mylan Company Information Table 79. Mylan Business Overview Table 80. Mylan Cobalamin API Sales (t), Price (USD/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Mylan Cobalamin API Product Portfolio Table 82. Mylan Recent Development Table 83. Pfizer Company Information Table 84. Pfizer Business Overview Table 85. Pfizer Cobalamin API Sales (t), Price (USD/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Pfizer Cobalamin API Product Portfolio Table 87. Pfizer Recent Development Table 88. Huaxin Pharmaceutical Company Information Table 89. Huaxin Pharmaceutical Business Overview Table 90. Huaxin Pharmaceutical Cobalamin API Sales (t), Price (USD/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Huaxin Pharmaceutical Cobalamin API Product Portfolio Table 92. Huaxin Pharmaceutical Recent Development Table 93. Sanofi-Aventis Company Information Table 94. Sanofi-Aventis Business Overview Table 95. Sanofi-Aventis Cobalamin API Sales (t), Price (USD/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Sanofi-Aventis Cobalamin API Product Portfolio Table 97. Sanofi-Aventis Recent Development Table 98. RLG Group Company Information Table 99. RLG Group Business Overview Table 100. RLG Group Cobalamin API Sales (t), Price (USD/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. RLG Group Cobalamin API Product Portfolio Table 102. RLG Group Recent Development Table 103. Luitpold Pharmaceuticals (Daiichi Sankyo) Company Information Table 104. Luitpold Pharmaceuticals (Daiichi Sankyo) Business Overview Table 105. Luitpold Pharmaceuticals (Daiichi Sankyo) Cobalamin API Sales (t), Price (USD/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Luitpold Pharmaceuticals (Daiichi Sankyo) Cobalamin API Product Portfolio Table 107. Luitpold Pharmaceuticals (Daiichi Sankyo) Recent Development Table 108. Jamieson Company Information Table 109. Jamieson Business Overview Table 110. Jamieson Cobalamin API Sales (t), Price (USD/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Jamieson Cobalamin API Product Portfolio Table 112. Jamieson Recent Development Table 113. Endo International Company Information Table 114. Endo International Business Overview Table 115. Endo International Cobalamin API Sales (t), Price (USD/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Endo International Cobalamin API Product Portfolio Table 117. Endo International Recent Development Table 118. CCEPCD Company Information Table 119. CCEPCD Business Overview Table 120. CCEPCD Cobalamin API Sales (t), Price (USD/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. CCEPCD Cobalamin API Product Portfolio Table 122. CCEPCD Recent Development Table 123. Bayer HealthCare Company Information Table 124. Bayer HealthCare Business Overview Table 125. Bayer HealthCare Cobalamin API Sales (t), Price (USD/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Bayer HealthCare Cobalamin API Product Portfolio Table 127. Bayer HealthCare Recent Development Table 128. ANGELINI Company Information Table 129. ANGELINI Business Overview Table 130. ANGELINI Cobalamin API Sales (t), Price (USD/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. ANGELINI Cobalamin API Product Portfolio Table 132. ANGELINI Recent Development Table 133. Key Raw Materials Table 134. Raw Materials Key Suppliers Table 135. Cobalamin API Distributors List Table 136. Cobalamin API Customers List Table 137. Research Programs/Design for This Report Table 138. Authors List of This Report Table 139. Secondary Sources Table 140. Primary Sources List of Figures Figure 1. Cobalamin API Product Image Figure 2. Global Cobalamin API Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cobalamin API Market Size (2021-2032) & (US$ Million) Figure 4. Global Cobalamin API Sales (2021-2032) & (t) Figure 5. Global Cobalamin API Average Price (USD/kg) & (2021-2032) Figure 6. Global Top 5 and 10 Cobalamin API Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Purity≥99% Image Figure 9. Purity<99% Image Figure 10. Global Cobalamin API Sales by Type (2021 VS 2025 VS 2032) & (t) Figure 11. Global Cobalamin API Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Cobalamin API Sales Market Share by Type (2021-2032) Figure 13. Global Cobalamin API Revenue by Type (2021 VS 2025 VS 2032) & (t) Figure 14. Global Cobalamin API Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Cobalamin API Revenue Market Share by Type (2021-2032) Figure 16. Cobalamin Injection Image Figure 17. Cobalamin Spray Image Figure 18. Oral Cobalamin Image Figure 19. Global Cobalamin API Sales by Application (2021 VS 2025 VS 2032) & (t) Figure 20. Global Cobalamin API Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Cobalamin API Sales Market Share by Application (2021-2032) Figure 22. Global Cobalamin API Revenue by Application (2021 VS 2025 VS 2032) & (t) Figure 23. Global Cobalamin API Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Cobalamin API Revenue Market Share by Application (2021-2032) Figure 25. North America Cobalamin API Sales and Growth Rate (2021-2032) & (t) Figure 26. North America Cobalamin API Sales Market Share by Country (2021-2032) Figure 27. U.S. Cobalamin API Sales and Growth Rate (2021-2032) & (t) Figure 28. Canada Cobalamin API Sales and Growth Rate (2021-2032) & (t) Figure 29. Mexico Cobalamin API Sales and Growth Rate (2021-2032) & (t) Figure 30. Europe Cobalamin API Sales and Growth Rate (2021-2032) & (t) Figure 31. Europe Cobalamin API Sales Market Share by Country (2021-2032) Figure 32. Germany Cobalamin API Sales and Growth Rate (2021-2032) & (t) Figure 33. France Cobalamin API Sales and Growth Rate (2021-2032) & (t) Figure 34. U.K. Cobalamin API Sales and Growth Rate (2021-2032) & (t) Figure 35. Italy Cobalamin API Sales and Growth Rate (2021-2032) & (t) Figure 36. Netherlands Cobalamin API Sales and Growth Rate (2021-2032) & (t) Figure 37. Asia Pacific Cobalamin API Sales and Growth Rate (2021-2032) & (t) Figure 38. Asia Pacific Cobalamin API Sales Market Share by Country (2021-2032) Figure 39. China Cobalamin API Sales and Growth Rate (2021-2032) & (t) Figure 40. Japan Cobalamin API Sales and Growth Rate (2021-2032) & (t) Figure 41. South Korea Cobalamin API Sales and Growth Rate (2021-2032) & (t) Figure 42. Southeast Asia Cobalamin API Sales and Growth Rate (2021-2032) & (t) Figure 43. India Cobalamin API Sales and Growth Rate (2021-2032) & (t) Figure 44. Australia Cobalamin API Sales and Growth Rate (2021-2032) & (t) Figure 45. South America, Middle East and Africa Cobalamin API Sales and Growth Rate (2021-2032) & (t) Figure 46. South America, Middle East and Africa Cobalamin API Sales Market Share by Country (2021-2032) Figure 47. Brazil Cobalamin API Sales and Growth Rate (2021-2032) & (t) Figure 48. South Africa Cobalamin API Sales and Growth Rate (2021-2032) & (t) Figure 49. Saudi Arabia Cobalamin API Sales and Growth Rate (2021-2032) & (t) Figure 50. Turkey Cobalamin API Sales and Growth Rate (2021-2032) & (t) Figure 51. Argentina Cobalamin API Sales and Growth Rate (2021-2032) & (t) Figure 52. UAE Cobalamin API Sales and Growth Rate (2021-2032) & (t) Figure 53. Egypt Cobalamin API Sales and Growth Rate (2021-2032) & (t) Figure 54. Chile Cobalamin API Sales and Growth Rate (2021-2032) & (t) Figure 55. Global Cobalamin API Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Cobalamin API Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Cobalamin API Revenue (2021-2032) & (US$ Million) Figure 58. North America Cobalamin API Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Cobalamin API Revenue (2021-2032) & (US$ Million) Figure 60. Europe Cobalamin API Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Cobalamin API Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Cobalamin API Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Cobalamin API Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Cobalamin API Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Cobalamin API Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Cobalamin API Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Purity≥99%
  • Purity<99%
Applications
  • Cobalamin Injection
  • Cobalamin Spray
  • Oral Cobalamin
Companies covered
  • Teva (Actavis)
  • Novartis
  • Merck
  • Mylan
  • Pfizer
  • Huaxin Pharmaceutical
  • Sanofi-Aventis
  • RLG Group
  • Luitpold Pharmaceuticals (Daiichi Sankyo)
  • Jamieson
  • Endo International
  • CCEPCD
  • Bayer HealthCare
  • ANGELINI

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Cobalamin API Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Cobalamin API Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Cobalamin API Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Cobalamin API Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Cobalamin API Market Dynamics
  1. 2.1 Cobalamin API Industry Trends
  2. 2.2 Cobalamin API Industry Drivers
  3. 2.3 Cobalamin API Industry Opportunities and Challenges
  4. 2.4 Cobalamin API Industry Restraints
3 Cobalamin API Market by Manufacturers
  1. 3.1 Global Cobalamin API Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Cobalamin API Sales by Manufacturers (2021-2026)
  3. 3.3 Global Cobalamin API Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Cobalamin API Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Cobalamin API Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Cobalamin API Manufacturers, Product Type & Application
  7. 3.7 Global Cobalamin API Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Cobalamin API Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Cobalamin API Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Cobalamin API Tier 1, Tier 2, and Tier 3
4 Cobalamin API Market by Type
  1. 4.1 Cobalamin API Type Introduction
  2. 4.1.1 Purity≥99%
  3. 4.1.2 Purity<99%
  4. 4.2 Global Cobalamin API Sales by Type
  5. 4.2.1 Global Cobalamin API Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Cobalamin API Sales by Type (2021-2032)
  7. 4.2.3 Global Cobalamin API Sales Market Share by Type (2021-2032)
  8. 4.3 Global Cobalamin API Revenue by Type
  9. 4.3.1 Global Cobalamin API Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Cobalamin API Revenue by Type (2021-2032)
  11. 4.3.3 Global Cobalamin API Revenue Market Share by Type (2021-2032)
5 Cobalamin API Market by Application
  1. 5.1 Cobalamin API Application Introduction
  2. 5.1.1 Cobalamin Injection
  3. 5.1.2 Cobalamin Spray
  4. 5.1.3 Oral Cobalamin
  5. 5.2 Global Cobalamin API Sales by Application
  6. 5.2.1 Global Cobalamin API Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Cobalamin API Sales by Application (2021-2032)
  8. 5.2.3 Global Cobalamin API Sales Market Share by Application (2021-2032)
  9. 5.3 Global Cobalamin API Revenue by Application
  10. 5.3.1 Global Cobalamin API Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Cobalamin API Revenue by Application (2021-2032)
  12. 5.3.3 Global Cobalamin API Revenue Market Share by Application (2021-2032)
6 Global Cobalamin API Sales by Region
  1. 6.1 Global Cobalamin API Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Cobalamin API Sales by Region (2021-2032)
  3. 6.2.1 Global Cobalamin API Sales by Region (2021-2026)
  4. 6.2.2 Global Cobalamin API Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Cobalamin API Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Cobalamin API Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Cobalamin API Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Cobalamin API Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Cobalamin API Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Cobalamin API Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Cobalamin API Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Cobalamin API Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Cobalamin API Revenue by Region
  1. 7.1 Global Cobalamin API Revenue by Region
  2. 7.1.1 Global Cobalamin API Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Cobalamin API Revenue by Region (2021-2026)
  4. 7.1.3 Global Cobalamin API Revenue by Region (2027-2032)
  5. 7.1.4 Global Cobalamin API Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Cobalamin API Revenue (2021-2032)
  8. 7.2.2 North America Cobalamin API Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Cobalamin API Revenue (2021-2032)
  11. 7.3.2 Europe Cobalamin API Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Cobalamin API Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Cobalamin API Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Cobalamin API Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Cobalamin API Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva (Actavis)
  2. 8.1.1 Teva (Actavis) Company Information
  3. 8.1.2 Teva (Actavis) Business Overview
  4. 8.1.3 Teva (Actavis) Cobalamin API Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Teva (Actavis) Cobalamin API Product Portfolio
  6. 8.1.5 Teva (Actavis) Recent Developments
  7. 8.2 Novartis
  8. 8.2.1 Novartis Company Information
  9. 8.2.2 Novartis Business Overview
  10. 8.2.3 Novartis Cobalamin API Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Novartis Cobalamin API Product Portfolio
  12. 8.2.5 Novartis Recent Developments
  13. 8.3 Merck
  14. 8.3.1 Merck Company Information
  15. 8.3.2 Merck Business Overview
  16. 8.3.3 Merck Cobalamin API Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Merck Cobalamin API Product Portfolio
  18. 8.3.5 Merck Recent Developments
  19. 8.4 Mylan
  20. 8.4.1 Mylan Company Information
  21. 8.4.2 Mylan Business Overview
  22. 8.4.3 Mylan Cobalamin API Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Mylan Cobalamin API Product Portfolio
  24. 8.4.5 Mylan Recent Developments
  25. 8.5 Pfizer
  26. 8.5.1 Pfizer Company Information
  27. 8.5.2 Pfizer Business Overview
  28. 8.5.3 Pfizer Cobalamin API Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Pfizer Cobalamin API Product Portfolio
  30. 8.5.5 Pfizer Recent Developments
  31. 8.6 Huaxin Pharmaceutical
  32. 8.6.1 Huaxin Pharmaceutical Company Information
  33. 8.6.2 Huaxin Pharmaceutical Business Overview
  34. 8.6.3 Huaxin Pharmaceutical Cobalamin API Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Huaxin Pharmaceutical Cobalamin API Product Portfolio
  36. 8.6.5 Huaxin Pharmaceutical Recent Developments
  37. 8.7 Sanofi-Aventis
  38. 8.7.1 Sanofi-Aventis Company Information
  39. 8.7.2 Sanofi-Aventis Business Overview
  40. 8.7.3 Sanofi-Aventis Cobalamin API Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Sanofi-Aventis Cobalamin API Product Portfolio
  42. 8.7.5 Sanofi-Aventis Recent Developments
  43. 8.8 RLG Group
  44. 8.8.1 RLG Group Company Information
  45. 8.8.2 RLG Group Business Overview
  46. 8.8.3 RLG Group Cobalamin API Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 RLG Group Cobalamin API Product Portfolio
  48. 8.8.5 RLG Group Recent Developments
  49. 8.9 Luitpold Pharmaceuticals (Daiichi Sankyo)
  50. 8.9.1 Luitpold Pharmaceuticals (Daiichi Sankyo) Company Information
  51. 8.9.2 Luitpold Pharmaceuticals (Daiichi Sankyo) Business Overview
  52. 8.9.3 Luitpold Pharmaceuticals (Daiichi Sankyo) Cobalamin API Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Luitpold Pharmaceuticals (Daiichi Sankyo) Cobalamin API Product Portfolio
  54. 8.9.5 Luitpold Pharmaceuticals (Daiichi Sankyo) Recent Developments
  55. 8.10 Jamieson
  56. 8.10.1 Jamieson Company Information
  57. 8.10.2 Jamieson Business Overview
  58. 8.10.3 Jamieson Cobalamin API Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Jamieson Cobalamin API Product Portfolio
  60. 8.10.5 Jamieson Recent Developments
  61. 8.11 Endo International
  62. 8.11.1 Endo International Company Information
  63. 8.11.2 Endo International Business Overview
  64. 8.11.3 Endo International Cobalamin API Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Endo International Cobalamin API Product Portfolio
  66. 8.11.5 Endo International Recent Developments
  67. 8.12 CCEPCD
  68. 8.12.1 CCEPCD Company Information
  69. 8.12.2 CCEPCD Business Overview
  70. 8.12.3 CCEPCD Cobalamin API Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 CCEPCD Cobalamin API Product Portfolio
  72. 8.12.5 CCEPCD Recent Developments
  73. 8.13 Bayer HealthCare
  74. 8.13.1 Bayer HealthCare Company Information
  75. 8.13.2 Bayer HealthCare Business Overview
  76. 8.13.3 Bayer HealthCare Cobalamin API Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Bayer HealthCare Cobalamin API Product Portfolio
  78. 8.13.5 Bayer HealthCare Recent Developments
  79. 8.14 ANGELINI
  80. 8.14.1 ANGELINI Company Information
  81. 8.14.2 ANGELINI Business Overview
  82. 8.14.3 ANGELINI Cobalamin API Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 ANGELINI Cobalamin API Product Portfolio
  84. 8.14.5 ANGELINI Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Cobalamin API Value Chain Analysis
  2. 9.1.1 Cobalamin API Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Cobalamin API Production Mode & Process
  6. 9.2 Cobalamin API Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Cobalamin API Distributors
  9. 9.2.3 Cobalamin API Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst